Skip to content
Join our Newsletter

BIV Today No. 7: Any reason to take issue with 3D-printed human tissue?

On BIV Today… Can we soon expect transplants from 3D-printed organs made using B.C. technology? The BIV tech panel (1:14) talks about Aspect Biosystems’ efforts to commercialize its human tissue innovations.
1302spinoffs02
Aspect Biosystems uses 3D bioprinters to create living tissue | Photo: Tyler Orton

On BIV Today…

Can we soon expect transplants from 3D-printed organs made using B.C. technology? The BIV tech panel (1:14) talks about Aspect Biosystems’ efforts to commercialize its human tissue innovations. The panel then delves into the economic uncertainty surrounding Tesla and how it bled into a testy earnings call with CEO Elon Musk.

Later, BIV reporter Patrick Blennerhassett (14:58) joins the show to discuss commentary from the World Economic Forum that examines how China intends to follow through with plans to reduce pollution.